Potential harmful effects of discontinuing ACE-inhibitors and ARBs in COVID-19 patients | eLife
Should Angiotensin-Converting Enzyme Inhibitors ever Be Used for the Management of Hypertension? | SpringerLink
Molecules | Free Full-Text | From Angiotensin II to Cyclic Peptides and Angiotensin Receptor Blockers (ARBs): Perspectives of ARBs in COVID-19 Therapy
Frontiers | Renin-Angiotensin System and Coronavirus Disease 2019: A Narrative Review
Effect of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers on cardiovascular events in patients with heart failure: a meta-analysis of randomized controlled trials | BMC Cardiovascular Disorders | Full Text
From ACE Inhibitors/ARBs to ARNIs in Coronary Artery Disease and Heart Failure (Part 2/5) - ScienceDirect
A Focus Series on Hypertension: ACE Inhibitors and ARBs - YouTube
Dual inhibition of the renin system by aliskiren and valsartan - The Lancet
Which Inhibitor of the Renin–Angiotensin System Should Be Used in Chronic Heart Failure and Acute Myocardial Infarction? | Circulation
How effectively do ACE inhibitors and ARBs prevent migraines? | MDedge Family Medicine
JCM | Free Full-Text | Angiotensin Converting Enzyme Inhibitors versus Receptor Blockers in Patients with Ventricular Tachyarrhythmias
NKF KDOQI Guidelines
ACEIs and ARBs and Their Correlation with COVID-19: A Review | IDR
ACE Inhibitor Pathway, Pharmacodynamics
Should Angiotensin II Receptor Blockers and Statins Be Combined? | Circulation
Dual renin-angiotensin system inhibition for prevention of renal and cardiovascular events: do the latest trials challenge existing evidence? | Cardiovascular Diabetology | Full Text
Angiotensin converting enzyme (ACE) inhibitors and angiotensin receptor blockers in COVID-19 - The Centre for Evidence-Based Medicine
ACE inhibitors and the renal regulation of blood pressure (practice) | Khan Academy
Review of evidence on using ACEi and ARBs in patients with hypertension and COVID-19 | SpringerLink
Angiotensin converting enzyme (ACE) inhibitors and angiotensin receptor blockers in COVID-19 - The Centre for Evidence-Based Medicine
Cureus | A Rare Case of Dose-Dependent Losartan-Induced Angioedema
A practical guide to antiproteinuric drugs in dogs
Cross-Reactivity of ACE Inhibitor–Induced Angioedema with ARBs
Therapeutic impact of the single fixed-dose combination with a high-dose angiotensin-receptor blocker and a low-dose thiazide diuretic in the management of hypertension: awaiting further accumulation of clinical evidence | Hypertension Research
